Your browser doesn't support javascript.
loading
Lynch Syndrome Limbo: Patient Understanding of Variants of Uncertain Significance.
Solomon, Ilana; Harrington, Elizabeth; Hooker, Gillian; Erby, Lori; Axilbund, Jennifer; Hampel, Heather; Semotiuk, Kara; Blanco, Amie; Klein, William M P; Giardiello, Francis; Leonard, Lori.
Afiliação
  • Solomon I; City of Hope National Medical Center, 1500 E. Duarte Rd., Duarte, CA, 91010, USA. isolomon@coh.org.
  • Harrington E; Stanford School of Medicine, Stanford, CA, USA.
  • Hooker G; NextDxGx, Franklin, TN, USA.
  • Erby L; National Human Genome Research Institute, Bethesda, MD, 20892, USA.
  • Axilbund J; Invitae, San Francisco, CA, USA.
  • Hampel H; The Ohio State University Comprehensive Cancer Institute, Columbus, OH, USA.
  • Semotiuk K; Mount Sinai Hospital Zane Cohen Centre for Digestive Diseases, Toronto, ON, Canada.
  • Blanco A; University of California San Francisco Helen Diller Family Comprehensive Cancer Treatment Center, San Francisco, CA, USA.
  • Klein WMP; Behavioral Research Program, National Cancer Institute, Rockville, MD, USA.
  • Giardiello F; Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, MD, USA.
  • Leonard L; Department of Development Sociology, Cornell University, New York, NY, USA.
J Genet Couns ; 26(4): 866-877, 2017 Aug.
Article em En | MEDLINE | ID: mdl-28127677
ABSTRACT
Providers and patients encounter challenges related to the management of Variants of Unknown Significance (VUS). A VUS introduces new counseling dilemmas for the understanding and psychosocial impact of uncertain genetic test results. This descriptive study uses Mishel's theory of uncertainty in illness to explore the experience of individuals who have received a VUS as part of the genetic testing process. Semi-structured interviews were conducted with 27 adult individuals who received a VUS for Lynch syndrome mismatch repair genes between 2002 and 2013. The interviews were transcribed and analyzed. Most individuals recalled their result and perceived various types of uncertainty associated with their VUS. Half of the participants appraised their variant as a danger and implemented coping strategies to reduce the threat of developing cancer. Mobilizing strategies to reduce their risk included vigilant cancer surveillance, information seeking and notifying relatives. The majority of participants were unaware of the possibility of a VUS before receiving their result and expected reclassification over time. These results provide insight into the ways healthcare providers can support patients who receive VUS for Lynch syndrome. Findings also provide direction for future work that can further explicate the impact of receiving a VUS.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adaptação Psicológica / Neoplasias Colorretais Hereditárias sem Polipose / Testes Genéticos / Conhecimentos, Atitudes e Prática em Saúde / Incerteza Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adaptação Psicológica / Neoplasias Colorretais Hereditárias sem Polipose / Testes Genéticos / Conhecimentos, Atitudes e Prática em Saúde / Incerteza Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article